Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
C Michael Lambert a Rheumatic
Diseases Unit, Department of Medicine, University of Edinburgh, Western
General Hospital, Edinburgh EH4 2XU, b Department of Public Health Sciences, Medical School,
University of Edinburgh, Edinburgh EH8 9AG
Correspondence to: Dr Lambert
Objective: To test the clinical equivalence
and resource consequences of day care with inpatient care for active
rheumatoid arthritis.
Design: Randomised controlled clinical trial with
integrated cost minimisation economic evaluation.
Setting: Rheumatic diseases unit at a teaching
hospital between 1994 and 1996.
Subjects: 118 consecutive patients with active
rheumatoid arthritis randomised to receive either day care or inpatient care.
Main outcome measures: Clinical assessments recorded
on admission, discharge, and follow up at 12 months comprised: the
health assessment questionnaire, Ritchie articular index, erythrocyte
sedimentation rate, hospital anxiety and depression scale, and
Steinbrocker functional class. Resource estimates were of the direct
and indirect costs relating to treatment for rheumatoid arthritis.
Secondary outcome measures (health utility) were ascertained by time
trade off and with the quality of well being scale.
Results: Both groups had improvement in scores on the
health assessment questionnaire and Ritchie index and erythrocyte sedimentation rate after hospital treatment (P<0.0001) but clinical outcome did not differ significantly between the groups either at
discharge or follow up. The mean hospital cost per patient for day
care, £798 (95% confidence interval £705 to £888), was lower than
for inpatient care, £1253 (£1155 to £1370), but this difference was
offset by higher community, travel, and readmission costs. The
difference in total cost per patient between day care and inpatient
care was small (£1789 (£1539 to £2027) v £2021
(£1834 to £2230)). Quantile regression analysis showed a cost
difference in favour of day care up to the 50th centile (£374; £639
to £109).
Conclusions: Day care and inpatient care for patients
with uncomplicated active rheumatoid arthritis have equivalent clinical
outcome with a small difference in overall resource cost in favour of
day care. The choice of management strategy may depend increasingly on
convenience, satisfaction, or more comprehensive health measures
reflecting the preferences of patients, providers, and service
commissioners.
Key messages